home / stock / apls / apls articles

APLS Articles, Apellis Pharmaceuticals Inc. - From 09/27/23

Stock Information
Company Name: Apellis Pharmaceuticals Inc.
Stock Symbol: APLS
Market: NASDAQ
Website: apellis.com
Menu
APLS APLS Quote APLS Short APLS News APLS Articles APLS Message Board
Get APLS Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after ...
ROSEN, A LEADING AND RANKED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 2 Deadline in Securities Class Action – APLS | Benzinga

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apel...

DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Apellis Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit | Benzinga

SAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Apellis class action lawsu...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Apellis, Party City, and Hayward and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds inves...
Stock Retreats As Bond Yields Climb Amid Oil Concerns, UAW Strike: What's Driving Markets Friday? | Benzinga

Risk appetite saw a setback during the final session of the week as stock markets dipped in response to a renewed surge in inflationary pressures. ...

Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday | Benzinga

B of A Securities raised the price target for Unity Software Inc. (NYSE: U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stoc...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS | Benzinga

NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apell...
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Apellis Investors of a Lead Plaintiff Deadline of October 2, 2023 | Benzinga

NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Attention Apellis Pharmaceuticals, Inc. ("Apellis") (NASDAQ:APLS) shareholders: The Law Off...

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS | Benzinga

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apell...

Apellis Pharmaceuticals Chief Research Officer Trades Company's Stock | Benzinga

Lukas Scheibler, Chief Research Officer at Apellis Pharmaceuticals (NASDAQ:APLS), reported a large insider sell on September 7, according to a new ...
Previous 10 Next 10